跳至主要内容
临床试验/ISRCTN16012111
ISRCTN16012111已完成未知

Evaluation of a Veterans Health Administration tool and policy to reduce patients’ risk of adverse events from opioid prescriptions: A stepped wedge cluster randomized trial

Department of Veterans Affairs Health Services Research & Development0 个研究点目标入组 100,000 人开始时间: 2017年5月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100,000

研究概览

简要总结

2019 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/30658658 protocol (added 21/01/2019) 2018 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/29950460 protocol (added 23/09/2019) 2020 Other publications in https://pubmed.ncbi.nlm.nih.gov/32576214/ strategy evaluation (added 25/06/2020) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35501628/ (added 03/05/2022) 2019 Other publications in https://doi.org/10.1080/08897077.2018.1540376 article commentary (added 15/06/2023) 2022 Results article in https://doi.org/10.1111/add.16110 secondary analysis (added 15/06/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Veterans Health Administration (VHA) patients with opioid prescription
  • 2. Identified by STORM to have a risk of SAE in the top 10% of all VHA patients

排除标准

  • Patients who are in palliative care or hospice care.

研究者

发起方
Department of Veterans Affairs Health Services Research & Development

相似试验